Mallinckrodt Stock Price Target and Analyst Ratings (NYSE:MNK)

Analyst Price Target for MNK

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

^$2.63

▲ +695.45% Upside Potential

This price target is based on 8 analysts offering 12 month price targets for Mallinckrodt in the last 3 months. The average price target is $2.63, with a high forecast of $4.00 and a low forecast of $1.50. The average price target represents a 695.45% upside from the last price of $0.33.

Hold

The current consensus among 8 investment analysts is to hold stock in Mallinckrodt. This Hold consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

0 strong buy ratings
3 buy ratings
10 hold ratings
2 sell ratings

Ratings as of

9/13/2019

0 strong buy ratings
3 buy ratings
10 hold ratings
2 sell ratings

Ratings as of

12/12/2019

0 strong buy ratings
3 buy ratings
9 hold ratings
3 sell ratings

Ratings as of

3/11/2020

0 strong buy ratings
3 buy ratings
8 hold ratings
3 sell ratings

Ratings as of

6/9/2020

0 strong buy ratings
0 buy ratings
6 hold ratings
4 sell ratings

Ratings as of

9/7/2020

0 strong buy ratings
0 buy ratings
6 hold ratings
4 sell ratings

Ratings as of

12/6/2020

0 strong buy ratings
0 buy ratings
5 hold ratings
4 sell ratings

Ratings as of

2/4/2021

0 strong buy ratings
0 buy ratings
5 hold ratings
3 sell ratings

Ratings as of

3/6/2021

Latest Recommendations

Show Most Recent Rating from Each Ratings Firm Show All Ratings

Date	Brokerage	Action	Rating	Price Target	Impact on Share Price	Details
9/15/2020	Raymond James	Reiterated Rating	Hold		Low	i
9/14/2020	SVB Leerink	Lower Price Target	Market Perform	$2.00 ➝ $1.50	High	i
8/5/2020	Barclays	Reiterated Rating	Hold		High	i
8/5/2020	BMO Capital Markets	Lower Price Target	Market Perform	$4.00 ➝ $2.00	High	i
8/4/2020	Piper Sandler	Downgrade	Neutral ➝ Underweight		High	i
5/19/2020	JPMorgan Chase & Co.	Downgrade	Neutral ➝ Underweight		Medium	i
5/6/2020	SVB Leerink	Boost Price Target	Market Perform	$2.00 ➝ $3.00	High	i
4/24/2020	Citigroup	Initiated Coverage	Sell		Low	i
4/2/2020	Barclays	Lower Price Target	Equal Weight	$5.00 ➝ $3.00	High	i
4/1/2020	Cfra	Lower Price Target	Hold	$6.00 ➝ $4.00	Low	i
2/26/2020	Bank of America	Boost Price Target	Underperform	$3.00	Low	i
1/22/2020	Wells Fargo & Company	Reiterated Rating	Hold		High	i Rating by David Maris at Wells Fargo & Company
12/9/2019	Wells Fargo & Company	Reiterated Rating	Hold		Medium	i Rating by David Maris at Wells Fargo & Company
10/9/2019	Wells Fargo & Company	Reiterated Rating	Hold		High	i Rating by David Maris at Wells Fargo & Company
9/10/2019	Barclays	Set Price Target	Hold	$5.00	N/A	i Rating by Balaji Prasad at Barclays PLC
9/9/2019	Stifel Nicolaus	Lower Price Target	Hold	$20.00 ➝ $8.00	High	i Rating by Annabel Samimy at Stifel Nicolaus
9/6/2019	Jefferies Financial Group	Set Price Target	Hold	$2.00	High	i Rating by Anthony Petrone at Jefferies Financial Group Inc.
9/6/2019	SVB Leerink	Set Price Target	Hold	$2.00	High	i Rating by Ami Fadia at SVB Leerink LLC
9/5/2019	BMO Capital Markets	Reiterated Rating	Outperform ➝ Market Perform		High	i Rating by Gary Nachman at BMO Capital Markets
9/4/2019	BMO Capital Markets	Downgrade	Outperform ➝ Hold	$3.00	Low	i Rating by Gary Nachman at BMO Capital Markets
8/28/2019	Barclays	Lower Price Target	Equal Weight	$7.00 ➝ $5.00	Low	i Rating by Balaji Prasad at Barclays PLC
8/12/2019	SunTrust Banks	Lower Price Target	Hold ➝ Positive	$7.00	High	i Rating by Gregg Gilbert at SunTrust Banks, Inc.
8/9/2019	Morgan Stanley	Set Price Target	Hold	$5.00	Low	i Rating by David Risinger at Morgan Stanley
8/7/2019	Stifel Nicolaus	Set Price Target	Hold	$20.00	High	i Rating by Annabel Samimy at Stifel Nicolaus
8/7/2019	BMO Capital Markets	Set Price Target	Buy	$19.00	High	i Rating by Gary Nachman at BMO Capital Markets
7/12/2019	Cantor Fitzgerald	Set Price Target	Buy	$18.00	Medium	i Rating by Louise Chen at Cantor Fitzgerald
7/11/2019	Jefferies Financial Group	Lower Price Target	Hold ➝ Reduce	$15.00 ➝ $10.00	Low	i
6/14/2019	Canaccord Genuity	Lower Price Target	Buy	$37.00 ➝ $22.00	High	i Rating by Dewey Steadman at Canaccord Genuity
6/12/2019	Cantor Fitzgerald	Lower Price Target	Overweight	$42.00 ➝ $18.00	Low	i
6/11/2019	Barclays	Initiated Coverage	Equal Weight ➝ Equal Weight	$11.00	Low	i
6/6/2019	Wells Fargo & Company	Lower Price Target	Market Perform	$25.00 ➝ $11.00	Low	i Rating by David Maris at Wells Fargo & Company
5/30/2019	Piper Jaffray Companies	Downgrade	Overweight ➝ Neutral	$39.00 ➝ $9.00	High	i Rating by David Amsellem at Piper Jaffray Companies
5/28/2019	Mizuho	Lower Price Target	Neutral	$22.00 ➝ $13.00	Low	i
5/24/2019	JPMorgan Chase & Co.	Lower Price Target	Neutral	$22.00 ➝ $11.00	High	i
5/22/2019	BMO Capital Markets	Reiterated Rating	Outperform	$23.00	High	i
5/22/2019	Jefferies Financial Group	Downgrade	Buy ➝ Hold	$25.00 ➝ $15.00	High	i
5/21/2019	Berenberg Bank	Reiterated Rating	Sell	$10.00 ➝ $5.00	High	i
5/16/2019	Mizuho	Lower Price Target	Neutral	$25.00 ➝ $22.00	Medium	i
5/14/2019	SunTrust Banks	Set Price Target	Hold	$20.00	Low	i Rating by Gregg Gilbert at SunTrust Banks, Inc.
3/19/2019	SunTrust Banks	Initiated Coverage	Hold ➝ Hold	$23.00	Medium	i
3/18/2019	Canaccord Genuity	Set Price Target	Buy	$40.00	Medium	i Rating by Dewey Steadman at Canaccord Genuity
2/28/2019	Morgan Stanley	Set Price Target	Hold	$32.00	Low	i Rating by David Risinger at Morgan Stanley
2/28/2019	Mizuho	Boost Price Target	Neutral	$26.00	Low	i
12/31/2018	B. Riley	Lower Price Target	Neutral	$21.00	Low	i
12/17/2018	Mizuho	Reiterated Rating	Neutral ➝ Neutral		High	i
12/7/2018	Wells Fargo & Company	Set Price Target	Hold	$27.00	Medium	i Rating by David Maris at Wells Fargo & Company
12/7/2018	Piper Jaffray Companies	Set Price Target	Buy	$39.00	High	i Rating by David Amsellem at Piper Jaffray Companies
11/25/2018	Canaccord Genuity	Set Price Target	Buy	$40.00	High	i Rating by Dewey Steadman at Canaccord Genuity
11/19/2018	Canaccord Genuity	Upgrade	Hold ➝ Buy	$34.00 ➝ $40.00	Medium	i Rating by Dewey Steadman at Canaccord Genuity
11/13/2018	Mizuho	Boost Price Target	Neutral	$29.00	Low	i
11/7/2018	Berenberg Bank	Set Price Target	Sell	$23.00	Medium	i Rating by Patrick Trucchio at Berenberg Bank
11/6/2018	Wells Fargo & Company	Set Price Target	Hold	$27.00	High	i Rating by David Maris at Wells Fargo & Company
11/6/2018	Mizuho	Reiterated Rating	Hold	$27.00	High	i
10/8/2018	Wells Fargo & Company	Set Price Target	Hold	$24.00	Low	i Rating by David Maris at Wells Fargo & Company
9/14/2018	Berenberg Bank	Initiated Coverage	Sell	$25.00	High	i
9/11/2018	The Goldman Sachs Group	Downgrade	Neutral ➝ Sell	$27.00 ➝ $28.00	Medium	i Rating by Dana Flanders at The Goldman Sachs Group, Inc.
8/24/2018	B. Riley	Boost Price Target	Neutral ➝ Neutral	$20.00 ➝ $37.00	Medium	i Rating by D. Buck at B. Riley
8/22/2018	Wells Fargo & Company	Reiterated Rating	Hold		Low	i Rating by David Maris at Wells Fargo & Company
8/19/2018	Canaccord Genuity	Set Price Target	Hold	$34.00	High	i Rating by Dewey Steadman at Canaccord Genuity
8/17/2018	Morgan Stanley	Boost Price Target	Equal Weight ➝ Equal Weight	$14.00 ➝ $35.00	High	i
8/13/2018	Canaccord Genuity	Reiterated Rating	Hold	$22.00	Low	i Rating by Dewey Steadman at Canaccord Genuity
8/13/2018	SunTrust Banks	Boost Price Target	Hold ➝ Positive	$32.00	Low	i
8/8/2018	Wells Fargo & Company	Set Price Target	Market Perform ➝ Market Perform	$21.00 ➝ $30.00	High	i Rating by David Maris at Wells Fargo & Company
8/8/2018	SVB Leerink	Boost Price Target	Market Perform	$12.00 ➝ $27.00	High	i
8/8/2018	Barclays	Boost Price Target	Underweight ➝ Underweight	$12.00 ➝ $20.00	High	i Rating by Douglas Tsao at Barclays PLC
8/8/2018	Stifel Nicolaus	Boost Price Target	Hold ➝ Hold	$18.00 ➝ $30.00	Medium	i
8/8/2018	Raymond James	Downgrade	Outperform ➝ Market Perform	$58.00	Medium	i
8/8/2018	Piper Jaffray Companies	Reiterated Rating	Buy	$39.00	Low	i
8/7/2018	BMO Capital Markets	Reiterated Rating	Outperform	$37.00	Low	i
8/7/2018	Cantor Fitzgerald	Reiterated Rating	Buy	$42.00	High	i Rating by Louise Chen at Cantor Fitzgerald
7/19/2018	Canaccord Genuity	Boost Price Target	Hold ➝ Hold	$14.00 ➝ $22.00	Low	i Rating by Dewey Steadman at Canaccord Genuity
7/9/2018	Wells Fargo & Company	Boost Price Target	Market Perform ➝ Market Perform	$15.00 ➝ $21.00	High	i Rating by David Maris at Wells Fargo & Company
6/28/2018	B. Riley	Boost Price Target	Neutral ➝ Neutral	$15.00 ➝ $20.00	Medium	i Rating by D. Buck at B. Riley
6/19/2018	SunTrust Banks	Boost Price Target	Hold	$21.00	Low	i
6/18/2018	Stifel Nicolaus	Boost Price Target	Hold ➝ Hold	$15.00 ➝ $18.00	Low	i
5/15/2018	Oppenheimer	Reiterated Rating	Hold		Low	i Rating by Christopher Liu at Oppenheimer Holdings Inc.
5/9/2018	Morgan Stanley	Lower Price Target	Equal Weight ➝ Equal Weight	$27.00 ➝ $14.00	High	i
5/9/2018	Barclays	Set Price Target	Underweight ➝ Underweight	$20.00 ➝ $12.00	High	i Rating by Douglas Tsao at Barclays PLC
5/8/2018	Canaccord Genuity	Set Price Target	Hold	$14.00	High	i Rating by Dewey Steadman at Canaccord Genuity
5/8/2018	Cantor Fitzgerald	Reiterated Rating	Buy	$42.00	Medium	i Rating by Louise Chen at Cantor Fitzgerald
5/4/2018	Wells Fargo & Company	Set Price Target	Hold	$17.50 ➝ $15.00	Low	i Rating by David Maris at Wells Fargo & Company
5/3/2018	Mizuho	Reiterated Rating	Hold	$15.00	Medium	i
5/2/2018	B. Riley	Initiated Coverage	Neutral ➝ Neutral	$15.00 ➝ $15.00	Low	i Rating by D. Buck at B. Riley
4/30/2018	Cantor Fitzgerald	Set Price Target	Buy	$42.00	Low	i Rating by Louise Chen at Cantor Fitzgerald
4/26/2018	Mizuho	Reiterated Rating	Hold	$15.00	Low	i
4/23/2018	SVB Leerink	Lower Price Target	Market Perform		Low	i Rating by A. Fadia at SVB Leerink LLC
4/20/2018	Mizuho	Reiterated Rating	Hold	$15.00	Low	i
4/12/2018	Stifel Nicolaus	Downgrade	Buy ➝ Hold	$50.00	High	i
4/12/2018	Wells Fargo & Company	Reiterated Rating	Hold		High	i Rating by David Maris at Wells Fargo & Company
4/11/2018	SunTrust Banks	Initiated Coverage	Hold	$15.00	High	i
4/2/2018	Cantor Fitzgerald	Set Price Target	Buy	$42.00	High	i Rating by Louise Chen at Cantor Fitzgerald
3/16/2018	Wells Fargo & Company	Set Price Target	Hold	$18.00	High	i Rating by David Maris at Wells Fargo & Company
3/9/2018	Mizuho	Reiterated Rating	Neutral ➝ Neutral	$21.00 ➝ $16.00	Medium	i
3/6/2018	Canaccord Genuity	Set Price Target	Hold	$20.00	High	i Rating by Dewey Steadman at Canaccord Genuity
2/27/2018	Oppenheimer	Reiterated Rating	Hold		High	i Rating by Derek Archila at Oppenheimer Holdings Inc.
2/27/2018	Cantor Fitzgerald	Set Price Target	Buy	$42.00	High	i Rating by Louise Chen at Cantor Fitzgerald
2/2/2018	Barclays	Downgrade	Equal Weight ➝ Underweight	$23.00 ➝ $20.00	Medium	i Rating by Douglas Tsao at Barclays PLC
1/9/2018	Mizuho	Reiterated Rating	Neutral ➝ Neutral	$22.00 ➝ $21.00	N/A	i
1/8/2018	Cantor Fitzgerald	Set Price Target	Buy	$42.00	Medium	i Rating by Louise Chen at Cantor Fitzgerald
1/7/2018	Canaccord Genuity	Set Price Target	Hold	$24.00	Medium	i Rating by Dewey Steadman at Canaccord Genuity
1/2/2018	SVB Leerink	Initiated Coverage	Mkt Perform ➝ Market Perform	$26.00	Medium	i Rating by A. Fadia at SVB Leerink LLC
1/1/2018	Wells Fargo & Company	Reiterated Rating	Hold		High	i Rating by David Maris at Wells Fargo & Company
1/1/2018	The Goldman Sachs Group	Reiterated Rating	Hold		High	i Rating by Dana Flanders at The Goldman Sachs Group, Inc.
1/1/2018	Canaccord Genuity	Set Price Target	Hold	$24.00	High	i Rating by Dewey Steadman at Canaccord Genuity
1/1/2018	Cantor Fitzgerald	Set Price Target	Buy	$42.00	High	i Rating by Louise Chen at Cantor Fitzgerald
12/26/2017	Cantor Fitzgerald	Set Price Target	Buy	$42.00	Low	i Rating by Louise Chen at Cantor Fitzgerald
12/26/2017	The Goldman Sachs Group	Reiterated Rating	Hold		Low	i Rating by Dana Flanders at The Goldman Sachs Group, Inc.
12/26/2017	Canaccord Genuity	Set Price Target	Hold	$24.00	Low	i Rating by Dewey Steadman at Canaccord Genuity
12/26/2017	Wells Fargo & Company	Reiterated Rating	Hold		Low	i Rating by David Maris at Wells Fargo & Company
12/12/2017	Barclays	Set Price Target	Hold	$23.00	High	i Rating by Douglas Tsao at Barclays PLC
11/26/2017	UBS Group	Downgrade	Buy ➝ Neutral	$70.00 ➝ $24.00	Medium	i Rating by Marc Goodman at UBS Group AG
11/22/2017	Oppenheimer	Reiterated Rating	Outperform ➝ Market Perform		N/A	i Rating by Derek Archila at Oppenheimer Holdings Inc.
11/14/2017	Canaccord Genuity	Set Price Target	Hold	$24.00	N/A	i Rating by Dewey Steadman at Canaccord Genuity
11/13/2017	UBS Group	Downgrade	Buy ➝ Neutral	$24.00	N/A	i Rating by Marc Goodman at UBS Group AG
11/8/2017	Canaccord Genuity	Lower Price Target	Buy	$38.00 ➝ $24.00	N/A	i Rating by Dewey Steadman at Canaccord Genuity
11/8/2017	Stifel Nicolaus	Lower Price Target	Buy	$70.00 ➝ $50.00	N/A	i
11/8/2017	Morgan Stanley	Lower Price Target	Equal Weight	$40.00 ➝ $27.00	N/A	i Rating by David Risinger at Morgan Stanley
11/8/2017	BMO Capital Markets	Lower Price Target	Outperform	$38.00	N/A	i
11/8/2017	The Goldman Sachs Group	Downgrade	Buy ➝ Neutral	$55.00	N/A	i
11/8/2017	Jefferies Financial Group	Initiated Coverage	Market Perform ➝ Buy	$60.00 ➝ $30.00	N/A	i
11/8/2017	Barclays	Downgrade	Overweight ➝ Equal Weight	$65.00 ➝ $23.00	N/A	i
11/8/2017	Wells Fargo & Company	Downgrade	Outperform ➝ Market Perform		N/A	i
11/7/2017	Citigroup	Downgrade	Buy ➝ Hold	$44.00 ➝ $28.00	N/A	i
11/7/2017	Deutsche Bank Aktiengesellschaft	Downgrade	Buy ➝ Hold	$44.00 ➝ $28.00	N/A	i Rating by Gregg Gilbert at Deutsche Bank Aktiengesellschaft
11/2/2017	Cantor Fitzgerald	Reiterated Rating	Buy	$52.00	N/A	i Rating by Louise Chen at Cantor Fitzgerald
10/21/2017	Piper Jaffray Companies	Set Price Target	Buy	$67.00	N/A	i Rating by David Amsellem at Piper Jaffray Companies
10/15/2017	Mizuho	Reiterated Rating	Hold	$40.00	N/A	i
10/6/2017	Stifel Nicolaus	Reiterated Rating	Buy		N/A	i
10/6/2017	Jefferies Financial Group	Reiterated Rating	Buy	$60.00	N/A	i Rating by David Steinberg at Jefferies Financial Group Inc.
10/6/2017	UBS Group	Set Price Target	Buy	$70.00	N/A	i Rating by Marc Goodman at UBS Group AG
10/5/2017	Piper Jaffray Companies	Reiterated Rating	Buy	$67.00	N/A	i Rating by David Amsellem at Piper Jaffray Companies
10/4/2017	Canaccord Genuity	Downgrade	Buy ➝ Hold	$77.00 ➝ $40.00	N/A	i Rating by Dewey Steadman at Canaccord Genuity
10/2/2017	Cantor Fitzgerald	Set Price Target	Buy	$52.00	Medium	i Rating by Louise Chen at Cantor Fitzgerald
9/28/2017	The Goldman Sachs Group	Initiated Coverage	Buy ➝ Buy	$55.00	Medium	i
9/19/2017	Oppenheimer	Lower Price Target		$70.00 ➝ $48.00	Low	i Rating by Derek Archila at Oppenheimer Holdings Inc.
9/15/2017	Piper Jaffray Companies	Reiterated Rating	Buy	$67.00	Low	i Rating by David Amsellem at Piper Jaffray Companies
9/14/2017	Deutsche Bank Aktiengesellschaft	Reiterated Rating	Buy	$56.00 ➝ $45.00	Low	i Rating by Gregg Gilbert at Deutsche Bank Aktiengesellschaft
9/14/2017	Citigroup	Lower Price Target	Reduce ➝ Buy	$45.00	Low	i
9/13/2017	Mizuho	Downgrade	Buy ➝ Neutral	$70.00 ➝ $40.00	Medium	i
9/6/2017	UBS Group	Reiterated Rating	Buy	$70.00	Low	i Rating by Marc Goodman at UBS Group AG
9/6/2017	Stifel Nicolaus	Reiterated Rating	Buy	$85.00	Low	i
9/6/2017	Mizuho	Reiterated Rating	Buy	$70.00	Low	i
9/6/2017	Morgan Stanley	Downgrade	Overweight ➝ Equal Weight	$65.00 ➝ $40.00	Low	i Rating by David Risinger at Morgan Stanley
9/5/2017	Cantor Fitzgerald	Reiterated Rating	Buy	$52.00	Low	i
8/25/2017	Jefferies Financial Group	Lower Price Target	Buy	$70.00 ➝ $60.00	Low	i Rating by David Steinberg at Jefferies Financial Group Inc.
8/9/2017	Mizuho	Reiterated Rating	Buy	$73.00 ➝ $70.00	Medium	i
8/9/2017	BMO Capital Markets	Reiterated Rating	Outperform	$69.00 ➝ $65.00	Low	i
8/9/2017	Raymond James	Lower Price Target	Outperform	$65.00 ➝ $58.00	Low	i
8/9/2017	Deutsche Bank Aktiengesellschaft	Set Price Target	Buy	$68.00 ➝ $56.00	Low	i Rating by Gregg Gilbert at Deutsche Bank Aktiengesellschaft
8/9/2017	UBS Group	Set Price Target	Buy	$70.00	High	i Rating by Marc Goodman at UBS Group AG
8/8/2017	Canaccord Genuity	Set Price Target	Buy	$87.00	High	i Rating by Dewey Steadman at Canaccord Genuity
8/8/2017	Oppenheimer	Set Price Target	Buy	$70.00	High	i Rating by Derek Archila at Oppenheimer Holdings Inc.
8/7/2017	Piper Jaffray Companies	Set Price Target	Buy	$85.00	Medium	i Rating by David Amsellem at Piper Jaffray Companies
8/3/2017	Jefferies Financial Group	Reiterated Rating	Buy	$70.00	Medium	i Rating by David Steinberg at Jefferies Financial Group Inc.
7/28/2017	BMO Capital Markets	Reiterated Rating	Buy	$69.00	Low	i
7/28/2017	Oppenheimer	Set Price Target	Buy	$70.00	Low	i Rating by Derek Archila at Oppenheimer Holdings Inc.
7/17/2017	Canaccord Genuity	Set Price Target	Buy	$87.00	Medium	i Rating by Dewey Steadman at Canaccord Genuity
7/16/2017	Piper Jaffray Companies	Set Price Target	Buy	$85.00	Medium	i Rating by David Amsellem at Piper Jaffray Companies
6/29/2017	UBS Group	Reiterated Rating	Buy	$100.00 ➝ $70.00	N/A	i Rating by Marc Goodman at UBS Group AG
6/21/2017	Wells Fargo & Company	Reiterated Rating	Outperform	$83.50	High	i Rating by David Maris at Wells Fargo & Company
6/20/2017	Jefferies Financial Group	Reiterated Rating	Buy	$70.00	High	i Rating by David Steinberg at Jefferies Financial Group Inc.
6/16/2017	Cantor Fitzgerald	Initiated Coverage	Overweight ➝ Overweight	$52.00	Low	i
5/31/2017	Morgan Stanley	Set Price Target	Buy	$65.00	Low	i Rating by David Risinger at Morgan Stanley
5/31/2017	Deutsche Bank Aktiengesellschaft	Set Price Target	Buy	$68.00	Low	i Rating by Gregg Gilbert at Deutsche Bank Aktiengesellschaft
5/31/2017	Mizuho	Reiterated Rating	Buy	$73.00	Low	i
5/31/2017	Jefferies Financial Group	Reiterated Rating	Buy	$70.00	Low	i Rating by David Steinberg at Jefferies Financial Group Inc.
5/24/2017	UBS Group	Set Price Target	Buy	$70.00	N/A	i Rating by Marc Goodman at UBS Group AG
5/10/2017	BMO Capital Markets	Lower Price Target	Outperform	$79.00 ➝ $69.00	Medium	i
5/9/2017	Canaccord Genuity	Lower Price Target	Buy ➝ Buy	$91.00 ➝ $87.00	Medium	i
4/21/2017	Jefferies Financial Group	Reiterated Rating	Buy	$70.00	High	i
4/1/2017	Guggenheim	Set Price Target	Buy	$98.00	Low	i Rating by Louise Chen at Guggenheim
3/20/2017	SVB Leerink	Reiterated Rating	Outperform		Low	i Rating by Jason Gerberry at SVB Leerink LLC
3/13/2017	Jefferies Financial Group	Downgrade	Buy	$95.00 ➝ $70.00	Low	i
2/22/2017	UBS Group	Set Price Target	Buy	$77.00	N/A	i Rating by Marc Goodman at UBS Group AG
2/21/2017	Canaccord Genuity	Initiated Coverage	Buy ➝ Buy	$91.00	N/A	i
2/8/2017	UBS Group	Set Price Target	Buy	$77.00	N/A	i Rating by Marc Goodman at UBS Group AG
2/8/2017	SVB Leerink	Set Price Target	Buy	$60.00	N/A	i Rating by Jason Gerberry at SVB Leerink LLC
2/8/2017	Piper Jaffray Companies	Lower Price Target	Overweight	$108.00 ➝ $83.00	N/A	i Rating by david amsellem at Piper Jaffray Companies
2/3/2017	Mizuho	Lower Price Target	Buy	$85.00 ➝ $69.00	N/A	i
1/25/2017	JPMorgan Chase & Co.	Set Price Target	Hold	$78.00	N/A	i Rating by Chris Schott at JPMorgan Chase & Co.
1/19/2017	Oppenheimer	Set Price Target	Buy	$72.00	N/A	i Rating by Derek Archila at Oppenheimer Holdings Inc.
1/19/2017	Wells Fargo & Company	Reiterated Rating	Buy		N/A	i Rating by David Maris at Wells Fargo & Company
1/19/2017	Guggenheim	Set Price Target	Buy	$98.00	N/A	i
1/19/2017	Mizuho	Reiterated Rating	Buy	$85.00	N/A	i
1/8/2017	Mizuho	Reiterated Rating	Buy	$85.00	N/A	i
12/29/2016	Guggenheim	Reiterated Rating	Buy	$98.00	N/A	i
12/20/2016	Oppenheimer	Reiterated Rating	Outperform		N/A	i Rating by Derek Archila at Oppenheimer Holdings Inc.
12/9/2016	Mizuho	Reiterated Rating	Buy	$87.00	N/A	i
12/7/2016	Oppenheimer	Reiterated Rating	Outperform		N/A	i
12/6/2016	Oppenheimer	Set Price Target	Buy	$115.00 ➝ $72.00	N/A	i Rating by Derek Archila at Oppenheimer Holdings Inc.
12/1/2016	Mizuho	Lower Price Target	Buy	$87.00 ➝ $85.00	N/A	i Rating by Irina Rivkind Koffler at Mizuho
11/30/2016	SVB Leerink	Set Price Target	Buy	$70.00	N/A	i Rating by Jason Gerberry at SVB Leerink LLC
11/30/2016	JPMorgan Chase & Co.	Lower Price Target	Neutral	$85.00 ➝ $78.00	N/A	i Rating by Chris Schott at JPMorgan Chase & Co.
11/30/2016	Deutsche Bank Aktiengesellschaft	Lower Price Target	Buy	$78.00 ➝ $73.00	N/A	i
11/29/2016	BMO Capital Markets	Reiterated Rating	Outperform	$92.00	N/A	i
11/25/2016	Mizuho	Lower Price Target	Buy	$87.00 ➝ $85.00	N/A	i Rating by Irina Rivkind Koffler at Mizuho
11/21/2016	Deutsche Bank Aktiengesellschaft	Reiterated Rating	Buy	$78.00	N/A	i
11/21/2016	UBS Group	Set Price Target	Buy	$92.00	N/A	i Rating by Marc Goodman at UBS Group AG
11/19/2016	SVB Leerink	Reiterated Rating	Outperform	$92.00	N/A	i Rating by jason gerberry at SVB Leerink LLC
11/19/2016	Mizuho	Reiterated Rating	Buy	$89.00 ➝ $87.00	N/A	i Rating by Irina Rivkind Koffler at Mizuho
11/18/2016	Raymond James	Initiated Coverage	Outperform	$72.00	N/A	i
10/21/2016	Wells Fargo & Company	Reiterated Rating	Outperform	$88.50 ➝ $83.50	N/A	i Rating by David Maris at Wells Fargo & Company
10/18/2016	Deutsche Bank Aktiengesellschaft	Reiterated Rating	Buy	$82.00 ➝ $78.00	N/A	i
9/29/2016	Mizuho	Lower Price Target	Buy	$91.00 ➝ $89.00	N/A	i Rating by Irina Rivkind Koffler at Mizuho
9/21/2016	Morgan Stanley	Reiterated Rating	Buy	$82.00	N/A	i Rating by david risinger at Morgan Stanley
9/16/2016	SVB Leerink	Reiterated Rating	Outperform	$91.00 ➝ $92.00	N/A	i Rating by Jason Gerberry at SVB Leerink LLC
9/8/2016	Morgan Stanley	Set Price Target	Buy	$82.00	N/A	i Rating by david risinger at Morgan Stanley
9/7/2016	Piper Jaffray Companies	Reiterated Rating	Overweight	$112.00 ➝ $105.00	N/A	i Rating by David Amsellem at Piper Jaffray Companies
8/31/2016	Deutsche Bank Aktiengesellschaft	Lower Price Target	Buy	$87.00 ➝ $84.00	N/A	i
8/29/2016	Mizuho	Reiterated Rating	Buy	$91.00	N/A	i Rating by Irina Rivkind Koffler at Mizuho
8/26/2016	The Goldman Sachs Group	Reiterated Rating	Neutral	$83.00	N/A	i Rating by Gary Nachman at The Goldman Sachs Group, Inc.
8/25/2016	BMO Capital Markets	Reiterated Rating	Positive ➝ Outperform	$93.00	N/A	i
8/25/2016	Barclays	Reiterated Rating	Overweight	$88.00	N/A	i
8/24/2016	Piper Jaffray Companies	Boost Price Target	Overweight	$103.00 ➝ $112.00	N/A	i Rating by David Amsellem at Piper Jaffray Companies
8/13/2016	Mizuho	Reiterated Rating	Buy	$91.00	N/A	i Rating by Irina Rivkind Koffler at Mizuho
8/12/2016	Stifel Nicolaus	Initiated Coverage	Buy	$95.00	N/A	i
8/4/2016	Jefferies Financial Group	Reiterated Rating	Buy	$85.00 ➝ $95.00	N/A	i Rating by Anthony Petrone at Jefferies Financial Group Inc.
8/3/2016	Piper Jaffray Companies	Set Price Target	Buy	$102.00 ➝ $103.00	N/A	i Rating by David Amsellem at Piper Jaffray Companies
8/3/2016	JPMorgan Chase & Co.	Set Price Target	Hold	$85.00	N/A	i Rating by Chris Schott at JPMorgan Chase & Co.
8/3/2016	Barclays	Boost Price Target	Overweight	$75.00 ➝ $88.00	N/A	i
8/3/2016	Guggenheim	Reiterated Rating	Buy	$98.00	N/A	i
8/3/2016	UBS Group	Boost Price Target	Buy	$85.00 ➝ $92.00	N/A	i
8/3/2016	SVB Leerink	Set Price Target	Buy	$84.00 ➝ $91.00	N/A	i
8/3/2016	Mizuho	Boost Price Target	Buy	$83.00 ➝ $91.00	N/A	i Rating by Irina Rivkind Koffler at Mizuho
7/21/2016	Mizuho	Boost Price Target	Buy	$80.00 ➝ $83.00	N/A	i Rating by Irina Rivkind Koffler at Mizuho
7/19/2016	BMO Capital Markets	Reiterated Rating	Buy	$84.00	N/A	i
6/28/2016	BMO Capital Markets	Initiated Coverage	Outperform	$84.00	N/A	i
6/10/2016	Wells Fargo & Company	Reiterated Rating	Buy		N/A	i Rating by David Maris at Wells Fargo & Company
6/6/2016	Mizuho	Reiterated Rating	Buy		N/A	i Rating by Irina Rivkind Koffler at Mizuho
6/6/2016	The Goldman Sachs Group	Initiated Coverage	Neutral	$73.00	N/A	i
5/4/2016	Oppenheimer	Reiterated Rating	Buy		N/A	i Rating by Rohit Vanjani at Oppenheimer Holdings Inc.
5/4/2016	Mizuho	Boost Price Target	Buy	$78.00 ➝ $80.00	N/A	i Rating by Irina Rivkind Koffler at Mizuho
5/4/2016	JPMorgan Chase & Co.	Reiterated Rating	Neutral	$100.00 ➝ $85.00	N/A	i
5/3/2016	Piper Jaffray Companies	Boost Price Target	Overweight	$97.00 ➝ $102.00	N/A	i Rating by David Amsellem at Piper Jaffray Companies
5/3/2016	Wells Fargo & Company	Reiterated Rating	Buy		N/A	i Rating by David Maris at Wells Fargo & Company
4/28/2016	Mizuho	Reiterated Rating	Buy	$78.00 ➝ $80.00	N/A	i Rating by Irina Rivkind Koffler at Mizuho
4/27/2016	Morgan Stanley	Reiterated Rating	Buy		N/A	i Rating by David Risinger at Morgan Stanley
4/21/2016	Piper Jaffray Companies	Reiterated Rating	Overweight	$97.00	N/A	i Rating by David Amsellem at Piper Jaffray Companies
4/2/2016	Jefferies Financial Group	Reiterated Rating	Buy	$85.00	N/A	i Rating by Anthony Petrone at Jefferies Financial Group Inc.
3/23/2016	Guggenheim	Reiterated Rating	Buy	$98.00	N/A	i Rating by Swati Kumar at Guggenheim
3/16/2016	Morgan Stanley	Reiterated Rating	Buy		N/A	i Rating by David Risinger at Morgan Stanley
3/16/2016	Northland Securities	Reiterated Rating	Buy	$95.00	N/A	i Rating by David Buck at Northland Securities

(Data available from 3/6/2016 forward)

Mallinckrodt Plc is a global specialty pharmaceuticals company. It develops, manufactures, markets and distributes both branded and generic specialty pharmaceutical products and medical imaging agents. It operates through the Specialty Brands and Specialty Generics segments. The Specialty Brands segment includes branded medicines. The Specialty Generics segment relates to specialty generic drugs, active pharmaceutical ingredients, as well as external manufacturing. The company was founded by Gustavo Mallinckrodt, Otto Mallinckrodt and Edward Mallinckrodt in 1867 and is headquartered in Blanchardstown, Dublin.

Today's Range

Now: $0.33

$0.30

$0.36

50 Day Range

MA: $0.34

$0.14

$0.75

52 Week Range

Now: $0.33

$0.75

$6.42

Volume

687,491 shs

Average Volume

6,488,121 shs

Market Capitalization

$27.91 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

3.06

Frequently Asked Questions

What sell-side analysts currently cover shares of Mallinckrodt?

The following sell-side analysts have issued reports on Mallinckrodt in the last twelve months: Barclays PLC, BMO Capital Markets, Cfra, Citigroup Inc., JPMorgan Chase & Co., Piper Sandler, Raymond James, and SVB Leerink LLC.
View the latest analyst ratings for MNK.

What is the current price target for Mallinckrodt?

4 Wall Street analysts have set twelve-month price targets for Mallinckrodt in the last year. Their average twelve-month price target is $2.63, suggesting a possible upside of 695.5%. Cfra has the highest price target set, predicting MNK will reach $4.00 in the next twelve months. SVB Leerink LLC has the lowest price target set, forecasting a price of $1.50 for Mallinckrodt in the next year.
View the latest price targets for MNK.

What is the current consensus analyst rating for Mallinckrodt?

Mallinckrodt currently has 3 sell ratings and 5 hold ratings from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in MNK, but not buy more shares or sell existing shares.
View the latest ratings for MNK.

What other companies compete with Mallinckrodt?

Other companies that are similar to Mallinckrodt include Oncolytics Biotech, American BriVision (Holding), Capricor Therapeutics, Marker Therapeutics, Lumos Pharma, Xynomic Pharmaceuticals, Actinium Pharmaceuticals, PhaseBio Pharmaceuticals, NervGen Pharma, Aravive, BetterLife Pharma, ProPhase Labs, Ocuphire Pharma, Moleculin Biotech and Avenue Therapeutics.

How do I contact Mallinckrodt's investor relations team?

Mallinckrodt's physical mailing address is COLLEGE BUSINESS & TECHNOLOGY PARK CRUISERATH BLANCHARDSTOWN, DUBLIN 15 L2, D15. The company's listed phone number is (531) 696-0000 and its investor relations email address is [email protected] The official website for Mallinckrodt is www.mallinckrodt.com.

NYSE:MNK - Mallinckrodt Stock Price Target and Predictions

Analyst Price Target for MNK

Past Monthly Recommendations

Latest Recommendations

Today's Range

50 Day Range

52 Week Range

Volume

Average Volume

Market Capitalization

P/E Ratio

Dividend Yield

Beta

Frequently Asked Questions

What sell-side analysts currently cover shares of Mallinckrodt?

What is the current price target for Mallinckrodt?

What is the current consensus analyst rating for Mallinckrodt?

What other companies compete with Mallinckrodt?

How do I contact Mallinckrodt's investor relations team?